Auditdata Adds NAL-NL3 Fitting System and Oldenburg Matrix Sentence Test to Measure

The dual additions give clinicians an integrated workflow to objectively measure, fit, and verify hearing aid benefit in noise — all within a single platform. Auditdata , the Copenhagen-based audiology software, hardware, and services company, has announced the availability of two new clinical tools in its Measure platform: the NAL-NL3 fitting system , developed by the National Acoustic Laboratories (NAL), and the...

Continue reading at Hearing Review

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

Clinicians already using Auditdata Measure can now run NAL-NL3 prescriptions and speech-in-noise verification within a single workflow, but no independent evidence is provided that this integration improves patient outcomes over existing setups.

✦ Why It Matters ✦

Integrating the latest NAL-NL3 prescription target and a validated speech-in-noise test into one platform lowers workflow friction for verification-oriented clinics and may nudge more practices toward evidence-based fitting protocols.

✦ Key Points ✦

01Auditdata added NAL-NL3 fitting prescription support to its Measure platform.
02The Oldenburg Matrix Sentence Test (speech-in-noise assessment) is now also built into Measure.
03Both additions enable fitting and verification of hearing aid benefit in noise within a single integrated workflow.
04No independent clinical evidence of outcome improvement is provided in the announcement.
05The update is relevant to clinics seeking to consolidate their fitting and verification tools.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

NAL-NL3 fitting prescription and the Oldenburg Matrix Sentence Test are now available within the Auditdata Measure platform.

press releasepromotional

The integration enables clinicians to fit and verify hearing aid benefit in noise within a single workflow.

press releasepromotional

✦ Related stories ✦

PubMed·Clinical trial·Hearing aids·6w ago

Unilateral and Bilateral Hearing Aids for Age-Related Hearing Loss: A Randomized Clinical Trial

of this RCT directly bear on bilateral vs. unilateral fitting decisions for adults with symmetrical mild-to-moderate age-related hearing loss; full-text review is essential, but this is potentially practice-changing depending on the direction and magnitude of the findings.

PubMed·Journal article·Hearing aids·6w ago

Hearing aids for mild to moderate hearing loss in adults

Audiologists should monitor this updated Cochrane review's conclusions closely; if it confirms benefit, it strengthens the case for fitting hearing aids in mild-loss patients who are currently under-served.

PubMed·Journal article·Hearing aids·3mo ago

Digital Interventions for First-Time Hearing Aid Users: A Systematic Review and Meta-Analysis of Efficacy and Effectiveness

Clinicians should consider incorporating evidence-based digital support tools (apps, online programmes) into onboarding protocols for first-time hearing aid users, pending the meta-analysis's specific effect-size findings.

PubMed·Journal article·Hearing aids·2w ago

Self-Fitting Versus Professional-Fitting Hearing Aids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The meta-analytic findings on self-fitting vs. professional-fitting outcomes should prompt audiologists to review their value proposition and counsel patients on where professional fitting adds measurable benefit, particularly for complex hearing profiles.

PubMed·Journal article·Hearing aids·4mo ago

Individuals with near-normal audiograms but perceived hearing difficulties can achieve aided outcomes on par with those of peers with mild hearing loss

Audiologists should consider fitting hearing aids for patients with near-normal audiograms who report significant hearing difficulty, as aided outcomes can match those of patients with confirmed mild hearing loss.

PubMed·Journal article·Hearing aids·3mo ago

The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias

If the study shows hearing-aid use reduces Alzheimer's-related plasma biomarkers, it would strengthen the case for early hearing rehabilitation as a potential dementia-prevention strategy, though findings should be weighed by sample size and study design before changing practice.

PubMed·Journal article·Hearing aids·5mo ago

Hearing Aid Efficacy-Timely Trial Finds Professional Guidance Trumps Costly Tech

This trial supports prioritising high-quality audiological fitting and counselling over premium hearing aid technology alone — audiologists should emphasise their professional value proposition when discussing device options with patients.